Bill > SB39

This bill extends current California cosmetic safety regulations related to vaginal suppositories containing boric acid, specifically addressing an important medical treatment for recurrent vaginal infections. The bill requires that starting January 1, 2027, vaginal suppository products containing boric acid must include a comprehensive warning label detailing potential risks, medical conditions that warrant consulting a doctor, and specific usage instructions, including warnings about pregnancy and sexual activity. The legislation delays the complete prohibition of these boric acid-containing vaginal suppositories until January 1, 2035, recognizing that these products represent one of the few available options for addressing certain vaginal infections. The bill also provides an exemption if the U.S. Food and Drug Administration (FDA) begins regulating these products as a drug, which would automatically remove them from the prohibition. The legislation is based on research from Johns Hopkins University and guidelines from medical organizations like the American College of Obstetricians and Gynecologists, which acknowledge boric acid's effectiveness in treating vaginal infections while also highlighting potential risks, particularly during pregnancy. The bill is classified as an urgency statute, meaning it will take effect immediately to ensure women have timely access to necessary medical and hygiene materials.

Agriculture and Natural Resources

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202520260SB39